Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Depreciation & Amortization (IS)EBIATLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsShares Outstanding
Ratios

Fresenius Medical Care AG (FMS) Depreciation & Amortization (IS) (2016 - 2025)

Historic Depreciation & Amortization (IS) for Fresenius Medical Care AG (FMS) over the last 17 years, with Q2 2025 value amounting to $1.7 billion.

  • Fresenius Medical Care AG's Depreciation & Amortization (IS) rose 128.8% to $1.7 billion in Q2 2025 from the same period last year, while for Jun 2025 it was $1.7 billion, marking a year-over-year increase of 128.8%. This contributed to the annual value of $1.6 billion for FY2024, which is 542.37% down from last year.
  • Latest data reveals that Fresenius Medical Care AG reported Depreciation & Amortization (IS) of $1.7 billion as of Q2 2025, which was up 128.8% from $1.6 billion recorded in Q1 2025.
  • In the past 5 years, Fresenius Medical Care AG's Depreciation & Amortization (IS) registered a high of $1.8 billion during Q4 2021, and its lowest value of $1.6 billion during Q1 2025.
  • Its 5-year average for Depreciation & Amortization (IS) is $1.7 billion, with a median of $1.7 billion in 2025.
  • Examining YoY changes over the last 5 years, Fresenius Medical Care AG's Depreciation & Amortization (IS) showed a top increase of 128.8% in 2025 and a maximum decrease of 671.01% in 2025.
  • Over the past 5 years, Fresenius Medical Care AG's Depreciation & Amortization (IS) (Quarter) stood at $1.8 billion in 2021, then fell by 3.39% to $1.8 billion in 2022, then decreased by 0.99% to $1.7 billion in 2023, then decreased by 5.42% to $1.6 billion in 2024, then rose by 4.07% to $1.7 billion in 2025.
  • Its Depreciation & Amortization (IS) was $1.7 billion in Q2 2025, compared to $1.6 billion in Q1 2025 and $1.6 billion in Q4 2024.